Granules India arm passes US FDA quality check for Hyderabad unit

The inspection, conducted from July 28 to August 1, 2025, confirmed the facility’s compliance with FDA quality standards and regulatory requirements. Granules Life Sciences Private Limited is engaged in the manufacturing of PFI and finished dosages. Shares of Granules India ended 1.64% in the green on Friday, December 12.

Source link